The positioning of myonectin links it to obesity (cluster 1) and humans (cluster 2), suggesting a potential role in translating findings on muscle-derived factors, possibly from animal studies in cluster 1, to their relevance in human metabolic diseases. Here, ERFE is linked to metabolic disease.